These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11932346)

  • 1. Hyperparathyroidism due to the so-called bone hunger syndrome in prostate cancer patients.
    Berruti A; Dogliotti L; Tucci M; Scarpa RM; Angeli A
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1910-1; author reply 1911. PubMed ID: 11932346
    [No Abstract]   [Full Text] [Related]  

  • 2. Pamidronate administration improves the secondary hyperparathyroidism due to "Bone Hunger Syndrome" in a patient with osteoblastic metastases from prostate cancer.
    Berruti A; Sperone P; Fasolis G; Torta M; Fontana D; Dogliotti L; Angeli A
    Prostate; 1997 Dec; 33(4):252-5. PubMed ID: 9397197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal effects of carcinoma of the breast and prostate.
    Percival RC
    Ann R Coll Surg Engl; 1986 Sep; 68(5):267-70. PubMed ID: 3789624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal-related events in prostate cancer.
    Smith MR
    Clin Adv Hematol Oncol; 2012 Aug; 10(8):535-6. PubMed ID: 23073052
    [No Abstract]   [Full Text] [Related]  

  • 5. Bone metabolism and new targets for intervention.
    Akduman B; Crawford ED
    Curr Urol Rep; 2007 May; 8(3):233-8. PubMed ID: 17459273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Secondary hyperparathyroidism in advanced prostate cancer].
    Quirosa Flores S; Varsavsky M; Valle Díaz De La Guardia F; Miján Ortiz JL; Muñoz Torres M; Raya Alvarez E; Zuluaga Gómez A
    Endocrinol Nutr; 2010 Mar; 57(3):100-4. PubMed ID: 20362521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Secondary hyperparathyroidism: especially in chronic renal failure (author's transl)].
    Tomita A
    Horumon To Rinsho; 1981 Nov; 29(11):1343-9. PubMed ID: 7341000
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostate cancer, serum parathyroid hormone, and the progression of skeletal metastases.
    Schwartz GG
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):478-83. PubMed ID: 18349265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term metabolic effects of pamidronate in patients with prostatic carcinoma and bone metastases.
    Pelger RC; Lycklama à Nijeholt AA; Papapoulos SE
    Lancet; 1989 Oct; 2(8667):865. PubMed ID: 2571787
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of orchidectomy on skeletal metabolism in metastatic prostate cancer.
    Clarke NW; McClure J; George NJ
    Scand J Urol Nephrol; 1993; 27(4):475-83. PubMed ID: 8159920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Secondary hyperparathyroidism in chronic kidney failure].
    Kalinin AP; Ivanov IA; Shcherbakova EO
    Ter Arkh; 1986; 58(8):143-8. PubMed ID: 3532407
    [No Abstract]   [Full Text] [Related]  

  • 12. Androgens and prostate cancer bone metastases: effects on both the seed and the soil.
    Yang W; Levine AC
    Endocrinol Metab Clin North Am; 2011 Sep; 40(3):643-53, x. PubMed ID: 21889726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypercalcemia and metastasis.
    Martin TJ
    Lancet; 1982 Nov; 2(8309):1216. PubMed ID: 6128516
    [No Abstract]   [Full Text] [Related]  

  • 14. When prostate cancer meets bone: control by wnts.
    Emami KH; Corey E
    Cancer Lett; 2007 Aug; 253(2):170-9. PubMed ID: 17462819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic gaps in bone formation may be a novel marker to monitor the osseous metastasis of prostate cancer.
    Koizumi M; Yonese J; Fukui I; Ogata E
    J Urol; 2002 Apr; 167(4):1863-6. PubMed ID: 11912449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary hyperparathyroidism.
    Rasmussen H
    Mt Sinai J Med; 1973; 40(3):462-73. PubMed ID: 4351493
    [No Abstract]   [Full Text] [Related]  

  • 17. [Calcium and bone metabolism after jejunal bypass operation for alimentary obesity: model for a intestinally-conditioned disorder (author's transl)].
    Kruse HP; Kuhlencordt F; Montz R; Ringe JD; Koch G
    Dtsch Med Wochenschr; 1981 Sep; 106(38):1219-23. PubMed ID: 7343280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Secondary hyperparathyroidism].
    Nakanishi S; Fukagawa M
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():341-6. PubMed ID: 16279659
    [No Abstract]   [Full Text] [Related]  

  • 19. Distinction between focally accelerated bone formation and osteomalacia in carcinoma of prostate metastasised to bone.
    Taube T; Beneton MN; Williams JL; McCloskey EV; Kanis JA
    Br J Urol; 1993 Jul; 72(1):98-103. PubMed ID: 8149187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo.
    Sun YX; Schneider A; Jung Y; Wang J; Dai J; Wang J; Cook K; Osman NI; Koh-Paige AJ; Shim H; Pienta KJ; Keller ET; McCauley LK; Taichman RS
    J Bone Miner Res; 2005 Feb; 20(2):318-29. PubMed ID: 15647826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.